Composition for Treating Uterine Fibroid (PP6)

• Status: Completed
• Trial end date: 2021-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

Pregnenolone & Pyridoxal Phosphate (PP6) for treating uterine fibroids in women pregnancy to lost the size fibroids and to dissolve fibroids.

Uterine fibroids are a very common finding in women pregnancy of reproductive age, fibroids fast grow in the first trimester pregnancy. PP6 against the rapid growth of fibroids under the influence of hormones during pregnancy. Use to PP6 think about regulating stable Oestrogen level and to dissolve fibroids.

This is a substantial insight into the pathogenesis of disease, with a clear path toward clinical application, or which would lead to a substantial advance and perfect in management or public health policy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Trieu, Nguyen Thi, M.D.
• Treatments: Pyridoxal; Pyridoxal Phosphate; Pyridoxine; Vitamin B 6

Criteria

Inclusion Criteria:

• Procedure to the treatment of fibroids in pregnancy and in women desiring future fertility.

Exclusion Criteria:

• Subserosal fibroids may be pedunculated hanging from a stalk inside or outside the uterus.